Brokerages Set HealthEquity, Inc. (NASDAQ:HQY) Target Price at $119.00

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been assigned a consensus rating of “Moderate Buy” from the fourteen analysts that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, ten have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $119.00.

Several equities research analysts have weighed in on the stock. Barrington Research restated an “outperform” rating and issued a $125.00 target price on shares of HealthEquity in a research note on Friday, August 29th. Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. KeyCorp reduced their target price on HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. Royal Bank Of Canada raised their price target on HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, September 3rd. Finally, BMO Capital Markets initiated coverage on shares of HealthEquity in a report on Thursday, November 13th. They set a “market perform” rating and a $100.00 price objective on the stock.

HealthEquity Price Performance

Shares of HQY stock opened at $104.58 on Wednesday. The stock’s 50-day moving average is $96.11 and its 200 day moving average is $96.84. HealthEquity has a 1-year low of $74.07 and a 1-year high of $116.65. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. The company has a market cap of $9.01 billion, a P/E ratio of 63.38, a PEG ratio of 1.36 and a beta of 0.47.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, hitting analysts’ consensus estimates of $0.92. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. The business had revenue of $325.80 million during the quarter, compared to the consensus estimate of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. Research analysts predict that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Insider Buying and Selling

In other HealthEquity news, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the transaction, the executive vice president owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. This trade represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Delano Ladd sold 6,000 shares of the business’s stock in a transaction on Friday, September 19th. The shares were sold at an average price of $94.11, for a total transaction of $564,660.00. Following the sale, the executive vice president directly owned 79,456 shares in the company, valued at $7,477,604.16. This trade represents a 7.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 10,781 shares of company stock worth $1,016,707 in the last 90 days. 1.50% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. Price T Rowe Associates Inc. MD raised its holdings in shares of HealthEquity by 995.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock worth $56,500,000 after purchasing an additional 580,988 shares during the last quarter. Westfield Capital Management Co. LP grew its position in HealthEquity by 124.6% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock worth $132,543,000 after purchasing an additional 701,819 shares during the period. Banco Bilbao Vizcaya Argentaria S.A. purchased a new position in shares of HealthEquity during the 2nd quarter valued at about $492,000. Ashford Capital Management Inc. lifted its holdings in shares of HealthEquity by 2.1% in the 1st quarter. Ashford Capital Management Inc. now owns 274,999 shares of the company’s stock valued at $24,302,000 after buying an additional 5,687 shares during the period. Finally, Artisan Partners Limited Partnership boosted its stake in shares of HealthEquity by 44.8% in the second quarter. Artisan Partners Limited Partnership now owns 621,647 shares of the company’s stock worth $65,124,000 after buying an additional 192,252 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.